Oxaliplatin/Capecitabine combination (Xelox) with or without targeted therapies in advanced colorectal cancer (ACRC) and pharmacokinetic analysis

被引：0
|
作者：
Gil-Delgado, M. [1 ,2 ,3 ,4 ]
Bastian, G. [1 ,2 ,3 ,4 ]
Spano, J. [1 ,2 ,3 ,4 ]
Paule, B. [1 ,2 ,3 ,4 ]
Des-Guetz, G. [1 ,2 ,3 ,4 ]
Bardier-Dupas, A. [1 ,2 ,3 ,4 ]
Khayat, D. [1 ,2 ,3 ,4 ]
机构：
[1] Med Oncol Serv, Paris, France
[2] Hop La Pitie Salpetriere, Paris, France
[3] Hop Paul Brousse, Villejuif, France
[4] Hop Avicenne, F-93009 Bobigny, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15068
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Capecitabine (X) following short-course capecitabine plus oxaliplatin (XELOX) in advanced colorectal cancer (CRC): Phase II XelQuali study
    Soe, W.
    Gollins, S.
    Waddell, T.
    Valle, J. W.
    Allen, J.
    Bentley, D.
    Morris, J.
    Lloyd, A.
    Swindell, R.
    Saunders, M. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] A PROSPECTIVE PHASE II STUDY OF CETUXIMAB IN COMBINATION WITH XELOX (CAPECITABINE AND OXALIPLATIN) IN PATIENTS WITH METASTATIC AND/OR RECURRENT ADVANCED GASTRIC CANCER
    Kim, C.
    Lee, J.
    Ryu, M.
    Chang, H. M.
    Kim, T. W.
    Kang, H. J.
    Lim, H. Y.
    Park, Y. S.
    Ryoo, B.
    Kang, Y.
    ANNALS OF ONCOLOGY, 2008, 19 : 174 - 174
  • [33] Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study
    T. Waddell
    S. Gollins
    W. Soe
    J. Valle
    J. Allen
    D. Bentley
    J. Morris
    A. Lloyd
    R. Swindell
    M. B. Taylor
    M. P. Saunders
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1111 - 1117
  • [34] Short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: Results of the phase II xelquali study
    Waddell, T.
    Gollins, S.
    Soe, W.
    Valle, J.
    Allen, J.
    Bentley, D.
    Morris, J.
    Lloyd, A.
    Swindell, R.
    Saunders, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 79 - 79
  • [35] Phase II trial of irinotecan and capecitabine in patients with advanced colorectal cancer (ACRC)
    Ahn, JB
    Jung, KH
    Park, YS
    Kim, YH
    Chang, HJ
    Sohn, DK
    Lim, SB
    Choi, HS
    Jeong, SY
    Park, JG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 299S - 299S
  • [36] Protracted 5-fluorouracil infusion plus oxaliplatin (FOX) versus capecitabine plus oxaliplatin (XELOX) as first-line treatment in advanced colorectal cancer (ACRC): Preliminary results of the Italian phase IIFOCA study
    Martoni, Andrea
    Pinto, Carmine
    Di Fabio, Francesca
    Lelli, Giorgio
    Llimpe, Fabiola Lorena Rojas
    Gentile, Anna Lisa
    Mutri, Vita
    Ballardini, Pierluigi
    Giaquinta, Stefania
    Piana, Edera
    ANNALS OF ONCOLOGY, 2005, 16 : 47 - 47
  • [37] Capecitabine and oxaliplatin (XelOx) in combination with radiotherapy after curative resection in locally advanced stomach cancer - Phase I study
    Mai, S. K.
    Hofheinz, R.
    Lukan, N.
    Boda-Heggemann, J.
    Staiger, W.
    Lohr, F.
    Post, S.
    Hochhaus, A.
    Wenz, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 111 - 111
  • [38] Efficacy and Safety of Capecitabine and Oxaliplatin Combination as Second-Line Treatment in Advanced Colorectal Cancer
    Heras, Panagiotis
    Kritikos, Konstantinos
    Hatzopoulos, Antonios
    Xourafas, Vasihos
    Kritikos, Nikolaos
    Karagiannis, Stefanos
    Mitsibounas, Dimitrios
    AMERICAN JOURNAL OF THERAPEUTICS, 2009, 16 (04) : 319 - 322
  • [39] Performance of capecitabine in novel combination therapies in colorectal cancer
    Pouya, Fahima Danesh
    Rasmi, Yousef
    Camci, Irem Yalim
    Tutar, Yusuf
    Nemati, Mohadeseh
    JOURNAL OF CHEMOTHERAPY, 2021, 33 (06) : 375 - 389
  • [40] Activity of the combination of bevacizumab (Bev) with capecitabine/irinotecan (CapIri/Bev) or capecitabine/oxaliplatin (CapOx/Bev) in advanced colorectal cancer (ACRC): A randomized phase II study of the AIO Colorectal Study Group (AIO trial 0604)
    Reinacher-Schick, A. C.
    Kubicka, S.
    Freier, W.
    Arnold, D.
    Dietrich, G.
    Geissler, M.
    Hegewisch-Becker, S.
    Graeven, U.
    Schmoll, H.
    Schmiegel, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345